Abstract
The plasma levels and diagnostic utility of Galactine 3 (GAL-3) in ovarian cancer patients
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have